Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial

Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access

(2021) Ibrahim Khalil et al.   VACCINE

Characterization of ShigETEC, a Novel Live Attenuated Combined Vaccine against Shigellae and ETEC

(2020) Shushan Harutyunyan et al.   Vaccines

Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis

(2019) John D Anderson et al.   Lancet Global Health

Serum IgG antibodies to Shigella lipopolysaccharide antigens – a correlate of protection against shigellosis

(2019) Dani Cohen et al.   Human Vaccines & Immunotherapeutics

Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016

(2018) Ibrahim A Khalil et al.   LANCET INFECTIOUS DISEASES

Status of vaccine research and development for Shigella

(2016) Sachin Mani et al.   VACCINE

Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study

(2013) Karen L Kotloff et al.   LANCET

Molecular mechanisms of enterotoxigenic Escherichia coli infection

(2009) James M. Fleckenstein et al.   MICROBES AND INFECTION